Bonnie Hammer
Executive VP, Research & Development Invenra Inc.
Seminars
Tuesday 13th October 2026
Showcasing Bispecific B-Body Platform & Trispecific T-Body Platform: Versatile Multispecific Systems for Broad Spectrum ADC Discovery
2:30 pm
- Combining proprietary B-Body and T-Body multispecific platforms for rapid screening to empirically identify optimal bispecific and trispecific ADC target combinations
- Describing generation of a 12×12 matrix of bispecific B-Body antibodies targeting 6 antigens to identify optimal pairs for trispecific T-Body ADCs for breast cancer
- Highlighting two powerful platforms for next-generation ADCs, offering promise for more effective and versatile breast cancer therapies
